Kyle T. Machynia

Kyle Machynia practices at Mountain West Surgical Center, LLC in Reno, Nevada.

Kyle Machynia's NPI, 1851848956, was assigned on September 6, 2016. Kyle Machynia holds Nevada license PA1762.

Kyle Machynia's primary practice is Mountain West Surgical Center, LLC, at 500 Damonte Ranch Pkwy, Reno, NV 89521 in Washoe County. The practice phone is (775) 460-4626.

Kyle Machynia's primary practice is Mountain West Surgical Center, LLC in Reno, Nevada. The medical group on file is Integrated Dermatology. Dmand AI also links Kyle Machynia to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kyle Machynia practices. Vendor and product names are available with a free account.

Physician assistant is Kyle Machynia's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Dmand AI has Kyle Machynia's licenses on file in 2 states: Nevada and Florida.

Dmand AI lists acne, acute skin infection, ankle or foot injury, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, facial skin infection and itchy rashes among the conditions Kyle Machynia treats.

CMS data shows 5,934 Medicare services from Kyle Machynia across 22 procedure codes in 2024, for 750 Medicare patients. Medicare paid $166,134 for them. Every service was in an office.

CMS counts 750 Medicare patients who saw Kyle Machynia in 2024. The largest group is 65 to 74, with 395 patients. 75% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Kyle Machynia's median patient age at 66, with 50% women.

In 2024, Kyle Machynia wrote 1,112 Medicare Part D claims for 451 patients. 90% of them were for generic drugs. CMS names the drug for 1,016 of them, across 20 drugs with 11 or more claims each, at $451,969 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Kyle Machynia for performance year 2024, reported as part of a group. Kyle Machynia accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 624 general payments to Kyle Machynia from 20 drug and device companies from 2024 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. Janssen Pharmaceuticals, Inc paid the most, $58,182.